Walleye Capital
BIOA

Walleye Capital’s BioAge Labs BIOA Stock Holding History

Walleye Capital’s Portfolio BIOA Stock Details BIOA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.65M Buy
151,674
+16,879
+13% +$325K 0.01% 1242
2025
Q4 		$1.78M Buy
134,795
+121,902
+945% +$1.08M 0.01% 1964
2025
Q3 		$75.8K Sell
12,893
-2,600
-17% -$12.2K ﹤0.01% 3843
2025
Q2 		$64K Buy
+15,493
New +$62.4K ﹤0.01% 3958
2024
Q4 		– Sell
-76,875
Closed -$1.6M – 5696
2024
Q3 		$1.6M Buy
+76,875
New +$1.54M ﹤0.01% 2188

Other funds holding BIOA

ACM
AH Capital Management Menlo Park, California $1.29B AUM 26.81% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return

Walleye Capital's BIOA Position: Q1 2026 in Review

Walleye Capital increased its BioAge Labs (BIOA) stake by 13% in Q1 2026, buying an estimated $325K and bringing the position to 151,674 shares worth $2.65M. The position accounts for 0.01% of the portfolio, ranked #1242.

Walleye Capital first reported a position in BIOA in Q3 2024 and has held it in 5 quarters since. 144 funds tracked by Wall St. Rank hold BIOA as of Q1 2026.

  • Walleye Capital held 151,674 shares of BioAge Labs worth $2.65M as of Q1 2026.
  • Walleye Capital bought 16,879 BioAge Labs shares in Q1 2026, an estimated $325K.
  • BioAge Labs made up 0.01% of Walleye Capital's portfolio in Q1 2026, its #1242 holding.
  • Walleye Capital first reported a position in BioAge Labs in Q3 2024 and has held it in 5 quarters since.
  • 144 funds tracked by Wall St. Rank held BioAge Labs as of Q1 2026.

Based on Walleye Capital's 13F filing for Q1 2026, filed 11 May 2026.